These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24338510)

  • 21. Induction of specific cytolytic T lymphocytes using fusions of hepatocellular carcinoma (HCC) patient-derived dendritic cells and allogeneic HCC cell line.
    Yin XY; Wang L; Lu MD; Li BJ; Huang JF
    Hepatogastroenterology; 2008; 55(81):155-9. PubMed ID: 18507097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative analysis of DC fused with tumor cells or transfected with tumor total RNA as potential cancer vaccines against hepatocellular carcinoma.
    Zhang HM; Zhang LW; Liu WC; Cheng J; Si XM; Ren J
    Cytotherapy; 2006; 8(6):580-8. PubMed ID: 17148035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma.
    Tomimaru Y; Mishra S; Safran H; Charpentier KP; Martin W; De Groot AS; Gregory SH; Wands JR
    Vaccine; 2015 Mar; 33(10):1256-66. PubMed ID: 25629522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor antigen pulsed dendritic cells enhance the cytolytic activity of tumor infiltrating lymphocytes in human hepatocellular cancer.
    Friedl J; Stift A; Paolini P; Roth E; Steger GG; Mader R; Jakesz R; Gnant MF
    Cancer Biother Radiopharm; 2000 Oct; 15(5):477-86. PubMed ID: 11155819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dendritic cells-mediated CTLs targeting hepatocellular carcinoma stem cells.
    Sun JC; Pan K; Chen MS; Wang QJ; Wang H; Ma HQ; Li YQ; Liang XT; Li JJ; Zhao JJ; Chen YB; Pang XH; Liu WL; Cao Y; Guan XY; Lian QZ; Xia JC
    Cancer Biol Ther; 2010 Aug; 10(4):368-75. PubMed ID: 20581468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cytotoxicity induced by HBsAg gene modified-dendritic cells against hepatocellular carcinoma cell HepG2.2.15].
    Yang JY; Ren J; Bai J; Liu DH; Fan L; Si XM; Teng ZH; Yang WT
    Ai Zheng; 2004 Aug; 23(8):914-7. PubMed ID: 15301714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific antitumor effects of tumor vaccine produced by autologous dendritic cells transfected with allogeneic osteosarcoma total RNA through electroporation in rats.
    Yu Z; Sun H; Zhang T; Yang T; Long H; Ma B
    Cancer Biol Ther; 2009 May; 8(10):973-80. PubMed ID: 19287216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dendritic cell-based vaccine targeting aspartate-β-hydroxylas represents a promising therapeutic strategy for HCC.
    Zhou Y; Li C; Shi G; Xu X; Luo X; Zhang Y; Fu J; Chen L; Zeng A
    Immunotherapy; 2019 Nov; 11(16):1399-1407. PubMed ID: 31608722
    [No Abstract]   [Full Text] [Related]  

  • 29. Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.
    Yang JY; Cao DY; Xue Y; Yu ZC; Liu WC
    Hum Immunol; 2010 Mar; 71(3):255-62. PubMed ID: 20036295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative analysis of cytotoxic T lymphocyte response induced by dendritic cells loaded with hepatocellular carcinoma -derived RNA or cell lysate.
    Pan K; Zhao JJ; Wang H; Li JJ; Liang XT; Sun JC; Chen YB; Ma HQ; Liu Q; Xia JC
    Int J Biol Sci; 2010 Oct; 6(7):639-48. PubMed ID: 20975822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antitumor effects and mechanisms of a dendritic cell vaccine which silenced SOCS1 by siRNA, stimulated by OK-432 and pulsed with lysate of HepG2 cells].
    Song HF; Zhou J; Pan K; Wang QJ; Wang H; Huang LX; Li YQ; Xia JC
    Ai Zheng; 2008 Jul; 27(7):685-91. PubMed ID: 18606059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of cytotoxic T lymphocytes from the peripheral blood of a hepatocellular carcinoma patient using melanoma antigen-1 (MAGE-1) peptide.
    Lu J; Leng X; Peng J; Mou D; Pang X; Shang X; Chen W
    Chin Med J (Engl); 2002 Jul; 115(7):1002-5. PubMed ID: 12150730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dendritic cells transfected with PEG10 recombinant adenovirus elicit anti-tumor immune response in vitro and in vivo.
    Peng W; Zhao G; Ma Y; Yu H; Wang X
    Vaccine; 2011 Apr; 29(18):3501-6. PubMed ID: 21352943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-tumor efficacy of a hepatocellular carcinoma vaccine based on dendritic cells combined with tumor-derived autophagosomes in murine models.
    Su S; Zhou H; Xue M; Liu JY; Ding L; Cao M; Zhou ZX; Hu HM; Wang LX
    Asian Pac J Cancer Prev; 2013; 14(5):3109-16. PubMed ID: 23803088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. STAT3-blocked whole-cell hepatoma vaccine induces cellular and humoral immune response against HCC.
    Han Q; Wang Y; Pang M; Zhang J
    J Exp Clin Cancer Res; 2017 Nov; 36(1):156. PubMed ID: 29115974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of antigen-specific immune responses by dendritic cells transduced with a recombinant lentiviral vector encoding MAGE-A3 gene.
    Lin L; Wei J; Chen Y; Huang A; Li KK; Zhang W
    J Cancer Res Clin Oncol; 2014 Feb; 140(2):281-9. PubMed ID: 24322180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autogeneic rna-electroporated CD40-ligand activated b-cells from hepatocellular carcinoma patients induce CD8+ T-cell responses ex vivo.
    Shen S; Xu Z; Qian X; Ding Y; Yu L; Liu B
    Exp Oncol; 2007 Jun; 29(2):137-43. PubMed ID: 17704747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Truncated TERT mRNA transfected dendritic cells evoke TERT specific antitumor response in vivo.
    Qiu J; Lil GW; Sui YF; Sun YJ; Huang YY; Si SY; Ge W; Song HP
    Hepatogastroenterology; 2007; 54(75):681-7. PubMed ID: 17591041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cells.
    Koido S; Homma S; Hara E; Mitsunaga M; Namiki Y; Takahara A; Nagasaki E; Komita H; Sagawa Y; Ohkusa T; Fujise K; Gong J; Tajiri H
    J Transl Med; 2008 Sep; 6():51. PubMed ID: 18793383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Inducing hepatocellular carcinoma-specific cytotoxic T lymphocyte response using formed by fusion of FastDCs and allogeneic human hepatocellular carcinoma cells].
    Guan X; Leng XS; Peng JR; Wei YH; Wang H; Yuan L
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3332-6. PubMed ID: 16409838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.